Source link : https://www.newshealth.biz/health-news/dual-targeted-car-t-yields-99-response-rate-in-pediatric-all/
SAN DIEGO — An investigational CAR T-cell therapy induced responses in nearly every single patient with childhood B-cell acute lymphoblastic leukemia (B-ALL), a researcher reported here. In a cohort of more than 300 patients with relapsed or refractory disease, 99.1% treated with the CD19/CD22-directed product bicistronic achieved a complete remission or complete remission with incomplete […]
Author : News Health
Publish date : 2024-12-07 15:00:00
Copyright for syndicated content belongs to the linked Source.